Ovoca Bio PLC
LSE:OVB

Watchlist Manager
Ovoca Bio PLC Logo
Ovoca Bio PLC
LSE:OVB
Watchlist
Price: 1.6 GBX Market Closed
Market Cap: 1.3m GBX
Have any thoughts about
Ovoca Bio PLC?
Write Note

Ovoca Bio PLC
Investor Relations

Ovoca Bio Plc is a clinical-stage biopharmaceutical company. The company is headquartered in Dublin, Dublin and currently employs 5 full-time employees. The firm is engaged in identifying and developing therapeutics targeting the treatment of female sexual dysfunction. The Company’s product BP101 is a synthetic peptide, administered through a nasal spray that is being developed for the treatment of female sexual dysfunction-hypoactive sexual desire disorder (HSDD). The Company’s subsidiaries include Silver Star Ltd, Bulun LLC, Magsel LLC, IVIX LLC and OVB (Australia) Pty Ltd. The firm operates in Ireland, the United Kingdom (UK) and Russia.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Timothy Rand McCutcheon
CEO & Director
No Bio Available
Mr. Dmitriy Nikitashenko
Vice President of Finance
No Bio Available
Reneta Nikolova
Corporate Secretary
No Bio Available

Contacts

Address
DUBLIN
DUBLIN
Dublin 2, 17 Pembroke Street Upper
Contacts
+35316619819.0
ovocabio.com